UVSQ, Inserm U1173, Infection et inflammation, Laboratory of Excellence INFLAMEX, Université Paris-Saclay, Montigny-le-Bretonneux, France.
Rheumatology Department, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, Île-de-France, France.
Ann Rheum Dis. 2021 Jul;80(7):840-847. doi: 10.1136/annrheumdis-2020-219816. Epub 2021 Jan 22.
To produce European League Against Rheumatism (EULAR) recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs).
Based on the literature reviews and expert opinion (through Delphi surveys), a taskforce of 23 members (12 experts in ultrasound in RMDs, 9 in methodology and biostatistics together with a patient research partner and a health professional in rheumatology) developed a checklist of items to be reported in every RMD study using ultrasound. This checklist was further refined by involving a panel of 79 external experts (musculoskeletal imaging experts, methodologists, journal editors), who evaluated its comprehensibility, feasibility and comprehensiveness. Agreement on each proposed item was assessed with an 11-point Likert scale, grading from 0 (total disagreement) to 10 (full agreement).
Two face-to-face meetings, as well as two Delphi rounds of voting, resulted in a final checklist of 23 items, including a glossary of terminology. Twenty-one of these were considered 'mandatory' items to be reported in every study (such as blinding, development of scoring systems, definition of target pathologies) and 2 'optional' to be reported only if applicable, such as possible confounding factors (ie, ambient conditions) or experience of the sonographers.
An EULAR taskforce developed a checklist to ensure transparent and comprehensive reporting of aspects concerning research and procedures that need to be presented in studies using ultrasound in RMDs. This checklist, if widely adopted by authors and editors, will greatly improve the interpretability of study development and results, including the assessment of validity, generalisability and applicability.
制定欧洲抗风湿病联盟（EULAR）关于在风湿和肌肉骨骼疾病（RMD）的超声研究报告的建议。
基于文献回顾和专家意见（通过 Delphi 调查），由 23 名成员组成的工作组（12 名 RMD 超声专家、9 名方法学和生物统计学专家以及一名患者研究伙伴和一名风湿病健康专业人员）制定了一份使用超声报告 RMD 研究的项目清单。通过涉及 79 名外部专家（肌肉骨骼成像专家、方法学家、期刊编辑）的小组进一步完善了该清单，他们评估了其可理解性、可行性和全面性。对每个提出的项目的一致性进行了 11 点李克特量表评估，从 0（完全不同意）到 10（完全同意）。
两次面对面会议以及两轮 Delphi 投票，最终形成了一份包含术语表的 23 项清单。其中 21 项被认为是每项研究都必须报告的“强制性”项目（如盲法、评分系统的制定、目标病变的定义），2 项是“可选”的，如果适用则报告，如可能的混杂因素（例如环境条件）或超声医师的经验。
EULAR 工作组制定了一份清单，以确保在 RMD 中使用超声的研究报告透明和全面地报告研究和程序方面的内容。如果作者和编辑广泛采用此清单，将极大地提高研究发展和结果的可解释性，包括有效性、普遍性和适用性的评估。
